Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 2Phase 1/2 1Phase 1 1

Status

Recruiting 6Active not recruiting 2

Sponsor Class

INDUSTRY 7OTHER 1

Study Type

Interventional 8

Sponsor

Cancer Type

Breast 8Gynecologic 1

Conditions

Breast Neoplasms 5Advanced Breast Cancer 2Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1ER+ HER2- Advanced Breast Cancer 1Breast Diseases 1

Interventions

Specimen Handling 642pembrolizumab 565Magnetic Resonance Spectroscopy 548Carboplatin 426Cisplatin 377Cyclophosphamide 374Biopsy 365Paclitaxel 306Nivolumab 303Gemcitabine 303Radiotherapy 274Bevacizumab 240Dexamethasone 209fludarabine 207Docetaxel 191durvalumab 183atezolizumab 177Oxaliplatin 174venetoclax 168Fluorouracil 167Rituximab 166Pemetrexed 164Capecitabine 161Radiation 159Doxorubicin 159Radiosurgery 150Etoposide 137Ipilimumab 135Leucovorin 133Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
AZD9833 × 90 days × Clear all
NCT07195227 2026-05-29

CADILLAC

MedSIR

Phase 2 Recruiting
150 enrolled
Breast

Breast Neoplasms

NCT05952557 2026-05-28

CAMBRIA-2

AstraZeneca

Phase 3 Recruiting
5,500 enrolled
Breast

Breast Neoplasms

NCT07427394 2026-05-28

SERENA-1b

AstraZeneca

Phase 2 Recruiting
24 enrolled
Breast

Advanced Breast Cancer

NCT06380751 2026-05-15

EvoPAR-BR01

AstraZeneca

Phase 3 Recruiting
500 enrolled
Breast

Advanced Breast Cancer

NCT06188520 2026-05-11

CYCAD-1

AstraZeneca

Phase 1/2 Recruiting
564 enrolled
BreastGynecologic

ER+ HER2- Advanced Breast Cancer

NCT05774951 2026-05-08

CAMBRIA-1

AstraZeneca

Phase 3 Recruiting
4,300 enrolled
Breast

Breast Neoplasms

NCT03616587 2026-04-30

SERENA-1

AstraZeneca

Phase 1 Active not recruiting
396 enrolled
Breast

Breast Neoplasms

NCT04964934 2026-04-21

SERENA-6

AstraZeneca

Phase 3 Active not recruiting
315 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon âš¡